Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy

16th April 2026 Uncategorised 0

Rather than relying on patient groups to make an impassioned plea, Roche aims to put doubts to rest around the controversial Duchenne muscular dystrophy gene therapy Elevidys with the rigor of another clinical study.

More: Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
Source: fierce